CMS has up to date its COVID-19 vaccine toolkit to explain the COVID-19 vaccines and boosters at the moment approved or authorized by the Meals and Drug Administration (FDA). Non-grandfathered group well being plans should cowl with out cost-sharing any vaccine approved below an Emergency Use Authorization (EUA) or authorized below a Biologics License Software (BLA) by the FDA instantly upon the vaccine turning into approved or authorized (see our Checkpoint article). Protection should be in line with the scope of the EUA or BLA for the actual vaccine, together with amendments permitting for the administration of a further dose to sure people, administration of booster doses, or the enlargement of the age demographic for whom the vaccine is allowed or authorized. The up to date toolkit now gives an in depth chronology of the EUAs and different approvals for the COVID-19 vaccines and boosters which were authorized to be used in the US.
EBIA Remark: Whereas the toolkit is primarily meant for well being insurers, its rationalization of mandated vaccine protection applies equally to self-insured well being plans, and the itemizing of vaccines and boosters that should be lined with out cost-sharing could also be helpful to plan sponsors. For extra data, see EBIA’s Group Well being Plan Mandates handbook at Part XVI.C “COVID-19: Mandated Protection of Diagnostic and Preventive Companies”) and EBIA’s Self-Insured Well being Plans handbook at Part XIII.C.11 (“Protection Mandates Referring to the COVID-19 Pandemic”).
Contributing Editors: EBIA Employees.
